Designing A Clinical Trial Home Nursing Solution Into Your Protocol From Day One
Clinical trial home nursing is usually treated as an after thought – added only after recruitment slips, sites are overloaded, or patients start dropping out. This resource explains how to build a home nursing model into your protocol from day one, so it works as a strategic design choice rather than a late-stage workaround. It walks through how to assess patient and site burden, decide what can safely be done off-site, define roles and oversight, and plan timelines and budgets realistically.
Too often, clinical trial home nursing is treated as a rescue solution. A study is struggling with recruitment. Patients are dropping out. Sites are overstretched. Only then does someone suggest, “What if we send nurses to the patient’s home?” – Cue protocol amendments, re-consent, new approvals, re training, delays, and cost.
But it doesn’t have to be like this.
If you use an innovative design that incorporates a clinical trial home nursing solution into your protocol from the very beginning, it becomes a strategic tool rather than a last-minute fix. You protect your timelines, reduce the burden on patients and sites, and make the trial easier to run day-to-day.
This article looks at how to do exactly that – step by step.
1. Start with burden, not with procedures
The temptation when thinking about clinical trial home nursing visits is to start with the question: “What can we do at the home instead of the site?”
But, a better starting point is: “Where is the patient burden score today?”.
Map the patient journey
Before you decide which visits might move to the home, take a simple look at the
patient experience:
- How often are patients required to attend the site?
- How far may the patient have to travel?
- How long do typical visits take door to door?
- What is the impact on family, work, school, childcare, or travel?
- Are there particular visits that patients frequently cancel or reschedule?
- What are the possible risks for a study visit remotely?
In many protocols, the length and complexity of the commitment is more of a barrier than the procedures themselves. A simple blood draw and set of questionnaires can easily consume half a day once travel, waiting time and logistics are included. These are exactly the kinds of visits that can often be moved closer to the patient.
Consider the site reality as well
Sites also carry a heavy load. Many experience:
- Limited staff and clinic space
- Multiple studies competing for the same resources
- Administrative and documentation requirements increasing year on year
When you ask site teams about their pain points, they rarely cite the more complex study visits. Those visits tend to be interesting, involve cross-department collaboration, and feel professionally meaningful. The strain often comes from routine, repetitive follow-up visits that create workload volume rather than variety. That is where a home nursing model can provide significant relief, if it is incorporated in the design early.
2. Decide what can safely be conducted remotely
Once you understand where the study burden lies, you can begin to look at which elements of the protocol might realistically and safely be delivered by the mobile nurses in the patient’s home, or other appropriate safe locations.
Remote -suitability vs site-dependent
As a simple rule of thumb:
Generally appropriate for home visits (with appropriate training and oversight):
- Vital signs and certain physical assessments
- Blood draws, sample processing and collection, using agreed logistics
- Administration of oral, subcutaneous, inhaled IMPs
- Infusions, where risk is well understood and mitigation is in place
- Questionnaires, patient-reported outcomes, and diaries
- Concomitant medication review and adherence checks
- AE safety checks and wellbeing assessments
Typically remaining at the site:
- First-in-human or first-dose-in-patient administrations
- High-risk infusions or procedures requiring immediate access to full emergency equipment & high dependency facilities
- Imaging and other instrument-heavy assessments
- Complex procedures needing specialist equipment or staff
The exact split will vary by protocol, patient population, and geography. The key is to make these decisions consciously and early in the protocol design process, instead of trying to retrofit them later.
Safety criteria and escalation
Safety must sit at the center of any decision to move procedures into the home. Ask:
- How stable is the target population likely to be?
- What is already known about the safety profile of the IMP?
- What are the plausible risks during or immediately after a home visit?
- What does “good escalation” look like in practice?
For every at-home visit, a clearly defined plan should be in place that specifies the nurses’ actions if an issue is identified : including the escalation pathway, responsible contacts, expected timelines , and how interactions are documented. The goal is not to shift all procedures into the home, but to move the right elements – that reduce burden without compromising safety and data integrity.
3. Put clinical trial home nursing visits explicitly into the protocol
Once you have a sense of where an in-home nursing solution could add value, it needs to be reflected clearly in the protocol. This is where many good ideas fall short.
Teams that use vague wording or assumptions about “flexible visits” often cause confusion later down the line.
Roles and responsibilities
Start with clarity on who does what:
- What tasks are delegated to the mobile research nurse?
- What remains strictly the responsibility of site staff?
- How does the Principal Investigator maintain oversight of home visits?
- How are tasks documented on the delegation log and in site files?
The protocol, and associated plans, should make it clear that mobile research nurses act as an extension of the site team, not as a separate parallel service, and should justify the uses of in-home clinical trial visits in terms that will be acceptable to review boards.
Visit schedules and windows
The schedule of assessments is the natural place to show how home visits fit into the study. For each visit, indicate whether it is:
- Site only
- Site or home – hybrid option
- Home or other appropriate off-site location only
If there is flexibility, define how the decision is made – for example, is it by patient preference, site capacity, or clinical judgement? Visit windows may also need adjustment. A nurse travelling to patients’ homes cannot cover the same number of visits per day as a site team working from a single location. Slightly wider visit windows may be required to keep the model workable while still respecting the scientific and safety needs of the study.
Procedures, supplies, and sample handling
For every visit that might be conducted remotely the protocol should specify:
- Exactly which procedures the nurse will perform
- What equipment and supplies are needed
- How samples are labelled, packaged, stored and transported
- Any differences in IMP handling and accountability in the home or off-site setting
These details can sit partly in the protocol and partly in the lab manual, pharmacy manual, and nursing manual – but they need to be thought through at protocol stage. Leaving them to be decided “later” is how amendments and deviations arise.
Data capture and documentation
From a data perspective, a home visit should look as much like a site visit as possible. Provide clarity on the below:
- Where is the nurse’s source documentation maintained?
- How does it feed into the eCRF and site records?
- What is the expected timeframe for data entry after each visit?
- How is data from ePRO or remote devices reconciled with nurse observations?
A consistent approach reassures monitors, auditors, and inspectors and helps avoid unexpected issues as data is generated.
4. Design with sites in mind from the beginning
One of the most common concerns about clinical trial home nursing is site perception. If sites feel bypassed or sidelined, engagement can suffer. Bringing at-home nursing into the protocol from day one gives you the opportunity to present it as a support for sites, not a threat.
- Use site advisory boards or feasibility discussions to sense-check which visits they would welcome support with.
- Clarify how remote nurses will communicate with sites before and after visits.
- Explain how source documentation and any safety issues arising from remote visits will be shared with the investigator.
The protocol and study plans should make it clear that the PI remains responsible for the conduct of the trial and for patient care, with mobile nurses acting as trained, protocol-specific support operating to agreed standards.
5. Embed quality, training and oversight
Clinical trial home nursing visits will attract attention from regulatory, QA and compliance teams, and rightly so. The question they will ask is simple: “How do we know that every home visit is being done properly?”
Designing in-home nursing visits into your clinical trial from day one means you can answer that question up front.
- Describe the training that remote research nurses will receive on the protocol and off-site visit procedures.
- Reference the SOP framework that governs their work.
- Outline how competencies are assessed and refreshed.
- Clarify how nurse performance is monitored and how issues are escalated.
If you are working with a partner, like WEP, that uses a full-time, in-house nursing model, you can also highlight the benefits of consistent standards across countries and studies, rather than relying on a loose network of freelancers with variable experience. These elements may sit in the protocol, monitoring plan, nursing manual, or quality agreement – but thinking about them at design stage avoids the need to retrofit governance later.
6. Plan budget and timelines realistically
There is no value in assuming that home nursing in clinical trials is cost neutral. It is an additional service with its own dedicated resource requirements. However, bringing it into your planning early changes the nature of the conversation. Rather than unplanned remedial expense when recruitment falters and dropout increase, remote nursing becomes a deliberate planned investment in feasibility, retention, and participant experience.
You can explore different design options and their impact on timelines and budget in advance:
- A base scenario with traditional site visits only
- An enhanced scenario with targeted home visits for high-burden visits
- A more ambitious scenario with broad remote/home visit options across the study
Because roles, visit schedules, and logistics are already clear in the protocol, it is much easier to forecast and manage the operational and financial impact.
7. A quick design checklist
Before you finalize your next protocol, it may be worth asking a few simple questions:
- Have we identified where patients and sites experience the highest burden?
- Have we defined which visits are suitable for the home , which are site-only, and which could be hybrid?
- Are roles and responsibilities for mobile nurses and site staff clearly described?
- Do visit windows and schedules reflect the realities of travel and home-based care?
- Have we specified how data, samples, and IMP will be handled for off-site visits?
- Are safety and escalation processes in place for issues arising in the home?
- Have we considered how sites will experience and communicate with the off-site nursing team?
- Is there a clear framework for training, quality, and oversight for every research nurse involved?
- Does our budget and timeline planning reflect the use of remote nursing from the outset?
If you can answer “yes” to most of these, you are already ahead of many studies that only consider home visits when problems appear.
If not, the protocol design stage is the right time to pause, reflect, and bring at-home research nursing into the design – not as an emergency measure, but as a deliberate way to make participation more realistic for patients and more sustainable for sites. Early planning enables informed trade off decisions across timelines and budgets.
Home nursing study designs deliver ROI by reducing recruitment friction, minimizing drop out, improving data continuity and ultimately lowering the risk of timeline extensions and protocol amendments. These gains often outweigh the incremental costs of mobile research nursing services.
Learn More About WEP’s Clinical Trial Nursing Capabilities
The WEP Nursing team works with Sponsors, CROs, and trial sites to provide clinical trial home nursing services worldwide, ensuring clinical excellence at every step of the journey.
If you would like to learn more about our capabilities, visit our Clinical Trial Nursing page.
About the Author
Juliet Hulse, Head of Clinical Nursing Operations
Juliet has 25+ years of global clinical research experience, with deep expertise in home health for clinical trials, direct-to-patient (DTP) models, regulatory oversight, and risk mitigation. Prior to joining WEP, she spent 11 years at Illingworth Research Group (a Syneos Health company), where she helped build the company’s clinical home health division and most recently served as Executive Director of Global Research Nurse Strategy and Patient Advocacy.
